Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Mixtard 30 being discontinued

The manufacturer of Mixtard® 30 has announced that this product will be discontinued by the 31st December 2010 due to declining demand.

Mixtard 30 is the only remaining Mixtard preparation since the discontinuation of the other presentations in 2007. Patients are being advised to contact their doctor or nurse to discuss treatment options.

This move has caused some concern according to the Pharmaceutical Journal with Diabetes UK, the charity for people with diabetes, stating that they asked the manufacturer to reconsider as it estimates some 90,000 people are currently using this product. A longer withdrawal period was also declined.

Diabetes UK has also made available a list of alternative products (PDF) which will aid clinicians and patients during this transition.

Action: Clinicians should be aware of this announcement and the additional workload it will involve. Alternative treatment options should be considered based upon patient factors and acquisition cost.

Share 'Mixtard 30 being discontinued' on Email Share 'Mixtard 30 being discontinued' on Delicious Share 'Mixtard 30 being discontinued' on Digg Share 'Mixtard 30 being discontinued' on Facebook Share 'Mixtard 30 being discontinued' on Google+ Share 'Mixtard 30 being discontinued' on reddit Share 'Mixtard 30 being discontinued' on StumbleUpon Share 'Mixtard 30 being discontinued' on Twitter

atomic-wealth

No Comments to “Mixtard 30 being discontinued”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,521 spam comments.

atomic-wealth
fond-illness
summer